Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 667 Medicine PhD Projects, Programmes & Scholarships for European Students (exc UK) in the UK

Discipline

Discipline

Medicine

Location

Location

United Kingdom

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a European student


Medicine PhD Projects, Programmes & Scholarships for European Students (exc UK) in the UK

We have 667 Medicine PhD Projects, Programmes & Scholarships for European Students (exc UK) in the UK

Non-linear cochlear mechanics: Models and measurements

Supervisory Team.   Ben Lineton. Project description. The mechanical response of the cochlea to sound exhibits an intriguing array of different non-linear phenomena, involving interactions across time and frequency. Read more

Personalised intervention approaches to improve and maintain physical activity following cardiac rehabilitation SSEHS/NP24

Cardiovascular diseases (CVD) are still a leading cause of death globally. Cardiac rehabilitation (CR) is an evidence-based intervention which is delivered after a cardiac event and aims to improve and restore health post cardiac event, and decrease the risk of future events. Read more

PhD in Social Research

The Sheffield Methods Institute (SMI) at the University of Sheffield invites applications to two fully-funded 3-year PhD scholarships. Read more

Optimising patient selection for Deep Brain Stimulation in Parkinson’s disease using multimodal machine learning

Parkinson’s disease has debilitating motor symptoms of tremor in the limbs, slowness of movement, and freezing, unable to move. A highly effective treatment is electrical stimulation deep in the motor regions of the midbrain. Read more

Is metabolic reprogramming the key to treatment failure in aggressive brain tumours? A multi-nuclear in vivo ultrahigh-field MRI approach.

Glioblastoma is the deadliest brain cancer with poor survival rates despite improved understanding of its genetic causes; novel treatments in lymphomas offer survival benefits for some people with lymphomas, but when treatments fail, the median survival time is ~5 months. Read more

Leveraging genetics to identify drug targets for respiratory disease

We have made significant advances in identifying genetic variants that increase the risk of lung function impairment and chronic obstructive pulmonary disease (COPD), including recently 26 genetic variants that are potentially deleterious to protein structure/function. Read more

Mechanism of Action Directed Implementation of a High Activity Anti-Pancreatic Cancer Lead

A 4-year PhD studentship is currently available in a Chemistry-Pharmacy-Bioscience team coordinated by Simon Woodward, Huw Williams and Isolda Romero-Canelón to be filled as soon as possible, for an October 2024 start. Read more

Climate change and perinatal health: combining epidemiological data with climate projection models

Rationale. Climate change will affect human health through changes to heat stress, sanitation, access to sufficient food and safe drinking water, disease patterns, migration, and frequency of extreme weather events. Read more
Last chance to apply

Utilising administrative data to inform FIT-guided suspected colorectal cancer referrals of symptomatic patients

Commercial partner: Alpha Laboratories Ltd. Colorectal cancer (CRC) is the third leading cause of cancer death worldwide. In the UK, around 43,000 new CRC cases are recorded annually, and its comparatively high incidence and mortality represent a considerable public health burden. Read more
Last chance to apply

Unravelling the effects of mitochondrial replacement therapy on mtDNA transmission

Commercial partner: Juno Genetics. Normal oocytes contain ~100,000 copies of mtDNA, which are effectively identical. Patients with mtDNA disease may harbour both mutant and normal mtDNA (heteroplasmy). Read more
Last chance to apply

Subgroup effects in antihypertensive and type 2 diabetes drug classes: a comparative effectiveness and safety study integrating real-world and genetic data

Commercial partner: Janssen. Pharmaceutical Companies of Johnson & Johnson. Estimating subgroup treatment effects from clinical trials is notably difficult due to the limited sample size and under-representation of patients with multimorbidity. Read more
Last chance to apply

Single Particle Liquid Biopsy Analysis for Acute Myocardial Infarction

Commercial partner: SPARTA Biodiscovery Ltd. Project background and description. Extracellular Vesicles (EVs) are nano-sized membrane vesicles with a phospholipid bilayer and are released by most cells, heathy and diseased, into biological fluids. Read more

Filtering Results